During the past decade, Lutheran Medical Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lutheran Medical Group" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "CytoSorbents, Inc" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Biosense Webster, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lutheran Medical Group" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "United States Department of Defense" with 1 trials as a collaborator and "University of Alabama at Birmingham" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lutheran Medical Group" are "Atrial Fibrillation" (2 trials), "Blood Loss, Postoperative" (2 trials), "Blood Loss, Surgical" (2 trials), "Hemorrhage Postoperative" (2 trials) and "Hemorrhage, Surgical" (2 trials). Many other conditions were trialed in "Lutheran Medical Group" in a lesser frequency.

Most popular intervention types in "Lutheran Medical Group" are "Drug" (8 trials), "Device" (6 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AC2993" (3 trials), "DrugSorb-ATR system" (2 trials), "Sham comparator" (2 trials) and "ACE-I (lisinopril) or ARB (losartan)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lutheran Medical Group" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lutheran Medical Group". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Lutheran Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lutheran Medical Group, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Lutheran Medical Group has several departments that took part in Clinical trials: "Indiana Ohio Heart" - 13 trials, "Heart Center Medical Group" - 2 trials